Monthly Archives: July 2015

Count Of Bearish Stocks Rising

The number of bearish stocks on Twitter are approaching the level recorded at the January lows for the S&P 500 Index (SPX). They’re now above their readings of last October. This is unusual given SPX is near all time highs so it’s something you’ll want to track carefully over the next few weeks. If the…

Count Of Bearish Stocks Rising

The number of bearish stocks on Twitter are approaching the level recorded at the January lows for the S&P 500 Index (SPX). They’re now above their readings of last October. This is unusual given SPX is near all time highs so it’s something you’ll want to track carefully over the next few weeks. If the…

‘Bull Trap’ In Nasdaq

There was some spill over from yesterday’s after hours disappointment in Apple (AAPL), but after a weak open, bulls were able to mount some challenge by close of business. However, today’s close was still below that of yesterday and registered as distribution. Hardest hit was the Semiconductor Index. It experienced a gap down, shedding 2.5%,…

Shift Happened

Allow me to limber up while I pat myself on the back – – or at least pat technical analysis on the back – – because, earlier today, I was vaguely remembering I had written a post that said something like “oil producers are the new gold miners”. With oil producers plummeting so consistently, I…

Apple Infallible After All

The last two earnings reports for Apple Inc. (NASDAQ:AAPL) have been out of this world. In January, the tech company posted an $18 billion profit, its strongest quarter by far, thanks to the release of the iPhone 6 and iPhone 6 Plus. Apple followed up it up its second-best quarter in terms of profit, raking in $13.6 billion, an impressive 27.2% jump…

E

Shares of Xoma (XOMA) are trading down 77% at Wednesday’s close after reporting failed results of its phase 3 trial in patients with Behcet’s disease Uveitis — a rare eye disease. The phase 3 trial is known as the EYEGUARD-B trial run by a French Pharmaceutical company known as Servier. Patients in the study were…